Ching-Lee Fukuda

Ching-Lee Fukuda — Patent Litigation Practice Summary

Specialty / focus. Fukuda is a trial and appellate patent litigator with roughly 30 years' experience spanning life sciences (pharma ANDA/Hatch-Waxman and biologics), medical devices/medtech, electronics, software, and chemicals, per her Sidley Austin and Morrison Foerster bios. Her tracked docket reflects that breadth: Astellas v. Dr. Reddy's (enzalutamide/Xtandi ANDA litigation), Omni MedSci v. Samsung (wearable biosensor patents in E.D. Tex. with parallel PTAB challenges), Evolution Malta v. Light & Wonder (gaming software), General Motors v. AutoConnect (automotive tech), and Express Mobile v. Facebook (software patents). She is also author of the treatise Winning the Patent Damages Case (Matthew Bender/LexisNexis, since 2022), matching her reputation for damages-trial work.

Side preference. Her tracked appearances are nearly evenly split — 5 plaintiff-side, 4 defendant-side — and she handles both roles. She has prosecuted for operating-company plaintiffs (Bayer, Astellas, GM, Evolution Malta) and defended operating companies and patent owners against NPE/PAE-style assertions (Samsung in Omni MedSci; Evolution Malta as patent owner against Unified Patents and Light & Wonder; previously Apple in Omni MedSci-related PTAB appeals). Sources describe her as representing both petitioners and patent owners in roughly 100 PTAB proceedings.

Firm context. Fukuda joined Morrison Foerster as a partner in New York in June 2026 (with Thomas Broughan), after more than a decade as a partner at Sidley Austin, where she headed the New York IP Litigation practice and co-led the global IP Litigation practice; before Sidley she was a partner at Ropes & Gray. The tracked-case records reflect mostly Sidley-era appearances, plus one Kramer Levin Naftalis & Frankel matter (Express Mobile v. Facebook). Legal 500 currently lists her as having left Sidley, consistent with the MoFo move.

Notable cases / outcomes. Reported highlights include leading the damages trial team in Bayer Healthcare v. Baxalta, which produced a $155M jury award (later ~$182M with supplemental damages) affirmed by the Federal Circuit; leading Nevro's arbitration and litigation wins against Mayo Clinic Ventures and the six-year Nevro v. Boston Scientific defense (20 patents, 60+ trade secrets) that ended with Boston Scientific paying Nevro $85M; and the Antares Pharma v. Medac Pharma defense, where patents were invalidated and affirmed in a precedential Federal Circuit opinion. In the tracked Light & Wonder v. Evolution Malta IPRs (IPR2025-01072 et al.), she represented patent owner Evolution Malta through a June 2026 precedential USPTO Director decision that vacated institution after a district court § 101 invalidation.

PTAB / IPR experience. PTAB work is a core part of her practice — more than 100 IPR/PGR proceedings on both sides, twice named LMG Life Sciences "Post-Grant Proceedings Attorney of the Year," and repeatedly listed among the PTAB Bar Association's "Top 50 Women in PTAB Trials." Her tracked Unified Patents v. Evolution Malta matters (lead counsel, defendant) and the Omni MedSci/Samsung PGR-IPR cluster confirm active PTAB engagement.

Bar / education. J.D., Fordham University School of Law; admitted to the New York bar in 1998.